Scott J. Antonia
Duke University(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Multiple Myeloma Research and Treatments, CAR-T cell therapy research, RNA Interference and Gene Delivery
Most-Cited Works
- → Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens(2023)66 cited
- → Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors(2017)54 cited
- → Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma(2023)16 cited
- → Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity(2023)14 cited
- → Attachment of tumor cells to endothelial monolayers: Detection of surface molecules involved in cell-cell binding(1989)7 cited
- → Orthogonal CRISPR screens to identify transcriptional and epigenetic regulators of human CD8 T cell function(2023)7 cited
- → Abstract CT103: A phase 1 first-in-human study of MEM-288 oncolytic virus in solid tumors including non-small cell lung cancer (NSCLC): impact on tumor and systemic T cell immunity(2023)4 cited
- → ATAC-seq, primary human T cells overexpressing BATF3 v1(2023)1 cited
- → Abstract 3193: Developing non-exhausted tumor infiltrating lymphocytes (TILs) as a therapy for glioblastoma(2023)1 cited
- → Supplementary Figure S1 from Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma(2023)